📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Medulloblastoma group 3 and 4 tumors comprise a clinically and biologically significant expression continuum reflecting human cerebellar development. (2022)

First Author: Williamson D

Attributed to: Anticipatory medicine: Can we identify, predict, and target mechanisms of disease relapse in childhood medulloblastoma? funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.celrep.2022.111162

PubMed Identifier: 35926460

Publication URI: http://europepmc.org/abstract/MED/35926460

Type: Journal Article/Review

Volume: 40

Parent Publication: Cell reports

Issue: 5